A 17% prevalence of anaphylaxis during chemonucleolysis among 35 patients who underwent a repeat chemonucleolysis procedure.
Bernstein
I L
IL
Bernstein
D I
DI
D000707:Anaphylaxis / Q000139:chemically induced*; D002917:Chymopapain / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007278:Injections, Spinal; D007404:Intervertebral Disc Chemolysis / Q000009:adverse effects; D012882:Skin Tests
D002917:Chymopapain